SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5xg5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FXR_A_ASCA3001_0
(LYSR TYPE REGULATOR
OF TSAMBCD)		 5xg5 MITSUBA-1
(synthetic
construct) 		4 / 8 HIS A 133
ARG A 135
ALA A  10
PRO A 113
 A2G  A 203 (-4.0A)
None
None
None
 1.00A 3fxrA-5xg5A:
undetectable		 3fxrA-5xg5A:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIH_A_CUA358_0
(PEPTIDYL-GLYCINE
ALPHA-AMIDATING
MONOOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		3 / 3 HIS A  37
HIS A  16
MET A  40
 A2G  A 201 (-4.0A)
A2G  A 201 (-3.7A)
None
 0.89A 3mihA-5xg5A:
undetectable		 3mihA-5xg5A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIH_A_CUA358_0
(PEPTIDYL-GLYCINE
ALPHA-AMIDATING
MONOOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		3 / 3 HIS A  85
HIS A  64
MET A  88
 A2G  A 202 (-4.0A)
A2G  A 202 (-3.7A)
None
 0.89A 3mihA-5xg5A:
undetectable		 3mihA-5xg5A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIH_A_CUA358_0
(PEPTIDYL-GLYCINE
ALPHA-AMIDATING
MONOOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		3 / 3 HIS A 133
HIS A 112
MET A 136
 A2G  A 203 (-4.0A)
A2G  A 203 (-3.7A)
None
 0.89A 3mihA-5xg5A:
undetectable		 3mihA-5xg5A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_A_AICA375_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 11 THR A  76
ASN A  74
ASN A  71
SER A 107
LEU A  78
 None
 1.25A 3ndvA-5xg5A:
undetectable
3ndvB-5xg5A:
undetectable		 3ndvA-5xg5A:
19.94
3ndvB-5xg5A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_C_AICC375_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 11 THR A  76
ASN A  74
ASN A  71
SER A 107
LEU A  78
 None
 1.28A 3ndvC-5xg5A:
undetectable
3ndvD-5xg5A:
undetectable		 3ndvC-5xg5A:
19.94
3ndvD-5xg5A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDV_D_AICD374_1
(BETA-PEPTIDYL
AMINOPEPTIDASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 11 LEU A  78
THR A  76
ASN A  74
ASN A  71
SER A 107
 None
 1.26A 3ndvC-5xg5A:
undetectable
3ndvD-5xg5A:
undetectable		 3ndvC-5xg5A:
19.94
3ndvD-5xg5A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A  44
VAL A  63
PHE A 140
ILE A   6
PHE A  92
 None
 1.29A 3t3rB-5xg5A:
undetectable		 3t3rB-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A  92
VAL A 111
PHE A  44
ILE A  54
PHE A 140
 None
 1.27A 3t3rB-5xg5A:
undetectable		 3t3rB-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A 140
VAL A  15
PHE A  92
ILE A 102
PHE A  44
 None
 1.26A 3t3rB-5xg5A:
undetectable		 3t3rB-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A  44
VAL A  63
PHE A 140
ILE A   6
PHE A  92
 None
 1.30A 3t3rC-5xg5A:
undetectable		 3t3rC-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A  92
VAL A 111
PHE A  44
ILE A  54
PHE A 140
 None
 1.29A 3t3rC-5xg5A:
undetectable		 3t3rC-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 PHE A 140
VAL A  15
PHE A  92
ILE A 102
PHE A  44
 None
 1.28A 3t3rC-5xg5A:
undetectable		 3t3rC-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_D_9PLD501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 10 PHE A  44
VAL A  63
PHE A 140
ILE A   6
PHE A  92
 None
 1.34A 3t3rD-5xg5A:
undetectable		 3t3rD-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_D_9PLD501_1
(CYTOCHROME P450 2A6)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 10 PHE A 140
VAL A  15
PHE A  92
ILE A 102
PHE A  44
 None
 1.31A 3t3rD-5xg5A:
undetectable		 3t3rD-5xg5A:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TJ7_A_ACTA609_0
(GBAA_1210 PROTEIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		3 / 3 LYS A  66
VAL A  79
HIS A  81
 A2G  A 202 (-4.7A)
None
A2G  A 202 (-3.9A)
 1.21A 3tj7A-5xg5A:
undetectable		 3tj7A-5xg5A:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		4 / 7 HIS A  33
ASP A  35
HIS A  16
PRO A  17
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-3.7A)
None
 1.06A 4hvrA-5xg5A:
undetectable		 4hvrA-5xg5A:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		4 / 7 HIS A  81
ASP A  83
HIS A  64
PRO A  65
 A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-3.7A)
None
 1.10A 4hvrA-5xg5A:
undetectable		 4hvrA-5xg5A:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)		 5xg5 MITSUBA-1
(synthetic
construct) 		4 / 7 HIS A 129
ASP A 131
HIS A 112
PRO A 113
 A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-3.7A)
None
 1.05A 4hvrA-5xg5A:
undetectable		 4hvrA-5xg5A:
20.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.16A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A  16
GLY A  20
VAL A  31
HIS A  33
ASP A  35
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
 0.79A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.13A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A  64
GLY A  68
VAL A  79
HIS A  81
ASP A  83
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
 0.86A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.14A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.16A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 8 HIS A  16
GLY A  20
VAL A  31
HIS A  33
ASP A  35
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
 0.85A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.16A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 8 HIS A  64
GLY A  67
VAL A  79
HIS A  81
ASP A  83
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
 0.84A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.14A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.15A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.12A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.12A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A 112
GLY A 115
VAL A 127
HIS A 129
ASP A 131
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
 0.86A 5f8yA-5xg5A:
27.0		 5f8yA-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.21A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 8 HIS A  16
GLY A  19
VAL A  31
HIS A  33
ASP A  35
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
 0.83A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.21A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 8 HIS A  64
GLY A  67
VAL A  79
HIS A  81
ASP A  83
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
 0.75A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 8 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.21A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 8 HIS A 112
GLY A 115
VAL A 127
HIS A 129
ASP A 131
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
 0.81A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.17A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A  16
GLY A  19
VAL A  31
HIS A  33
ASP A  35
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
 0.83A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.16A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.15A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A 112
GLY A 115
VAL A 127
HIS A 129
ASP A 131
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
 0.82A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  16
GLY A  19
GLY A  20
VAL A  31
HIS A  33
ASP A  35
HIS A  37
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.3A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
A2G  A 201 (-4.0A)
 0.22A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A  16
GLY A  20
VAL A  31
HIS A  33
ASP A  35
 A2G  A 201 (-3.7A)
A2G  A 201 (-3.1A)
None
A2G  A 201 (-3.7A)
A2G  A 201 (-3.5A)
 0.77A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A  64
GLY A  67
GLY A  68
VAL A  79
HIS A  81
ASP A  83
HIS A  85
 A2G  A 202 (-3.7A)
A2G  A 202 (-3.3A)
A2G  A 202 (-3.3A)
None
A2G  A 202 (-3.9A)
A2G  A 202 (-3.6A)
A2G  A 202 (-4.0A)
 0.14A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		7 / 9 HIS A 112
GLY A 115
GLY A 116
VAL A 127
HIS A 129
ASP A 131
HIS A 133
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
A2G  A 203 (-4.0A)
 0.19A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)		 5xg5 MITSUBA-1
(synthetic
construct) 		5 / 9 HIS A 112
GLY A 116
VAL A 127
HIS A 129
ASP A 131
 A2G  A 203 (-3.7A)
A2G  A 203 (-3.2A)
None
A2G  A 203 (-3.8A)
A2G  A 203 (-3.6A)
 0.79A 5f8yB-5xg5A:
27.0		 5f8yB-5xg5A:
59.09